硬化療法の世界市場2020-2026:洗剤、浸透圧剤、化学刺激剤

QYResearchが発行した調査報告書(QYR20AP02122)
◆英語タイトル:Global Sclerotherapy Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP02122
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:117
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、硬化療法の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、硬化療法のグローバル市場動向、メーカー別競争状況、種類別市場規模(洗剤、浸透圧剤、化学刺激剤)、用途別市場規模(静脈疾患、消化管出血、気管支胸膜f、嚢胞性疾患)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・硬化療法の種類別市場2015-2026:洗剤、浸透圧剤、化学刺激剤
・硬化療法の用途別市場2015-2026:静脈疾患、消化管出血、気管支胸膜f、嚢胞性疾患
・硬化療法の北米市場分析
・硬化療法のアジア市場分析
・硬化療法の中南米市場分析
・硬化療法の中東・アフリカ市場分析
・関連企業情報:BTG、Kreussler、LGM Pharma、Troikaa、Changan Tianyu group、Bioniche Pharma Group Ltd、Omega Pharmaceuticals、Angiodynamics、ENDO-FLEX、MTW ENDOSKOPIE、Cook Medical
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.Now more respected hospital minimally invasive surgical procedure, Sclerotherapy Treatment is relatively old. And there is a lot of shortcomings hardener. For example, it will be very painful in the course of treatment. But also produce pigmentation, or inflammation, swelling and other consequences, so I do not recommend using this method for the treatment of vascular malformations
Average industry gross margin is about 63.95%. However, due to the emergence of new treatments is not recommended investment.
In 2019, the global Sclerotherapy market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Sclerotherapy.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Sclerotherapy market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Sclerotherapy market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Sclerotherapy market. Readers of the report can become informed about current and future trends of the global Sclerotherapy market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Sclerotherapy markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Sclerotherapy market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Sclerotherapy market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Sclerotherapy market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Sclerotherapy market is segmented into
Detergents
Osmotic agents
Chemical irritants

Market Segment by Application, the Sclerotherapy market is segmented into
Venous disease
Gastrointestinal bleeding
Bronchopleural fistula
Cystic disease

This report includes the following manufacturers; we can also add the other companies as you want.
BTG
Kreussler
LGM Pharma
Troikaa
Changan Tianyu group
Bioniche Pharma Group Ltd
Omega Pharmaceuticals
Angiodynamics
ENDO-FLEX
MTW ENDOSKOPIE
Cook Medical

The study objectives are:
To analyze and research the global Sclerotherapy status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Sclerotherapy manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Sclerotherapy are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Sclerotherapy Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Sclerotherapy Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Detergents
1.3.3 Osmotic agents
1.3.4 Chemical irritants
1.4 Market Segment by Application
1.4.1 Global Sclerotherapy Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Venous disease
1.4.3 Gastrointestinal bleeding
1.4.4 Bronchopleural fistula
1.4.5 Cystic disease
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Sclerotherapy Revenue (2015-2026)
2.1.1 Global Sclerotherapy Revenue (2015-2026)
2.1.2 Global Sclerotherapy Sales (2015-2026)
2.2 Sclerotherapy Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Sclerotherapy Sales by Regions (2015-2020)
2.2.2 Global Sclerotherapy Revenue by Regions (2015-2020)
2.3 Global Top Sclerotherapy Regions (Countries) Ranking by Market Size
2.4 Sclerotherapy Industry Trends
2.4.1 Sclerotherapy Market Top Trends
2.4.2 Market Drivers
2.4.3 Sclerotherapy Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Sclerotherapy Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Sclerotherapy Manufacturers by Sales (2015-2020)
3.1.1 Global Sclerotherapy Sales by Manufacturers (2015-2020)
3.1.2 Global Sclerotherapy Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Sclerotherapy Sales in 2019
3.2 Global Top Manufacturers Sclerotherapy by Revenue
3.2.1 Global Sclerotherapy Revenue by Manufacturers (2015-2020)
3.2.2 Global Sclerotherapy Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Sclerotherapy Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sclerotherapy as of 2019)
3.4 Global Sclerotherapy Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Sclerotherapy Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Sclerotherapy Market
3.7 Key Manufacturers Sclerotherapy Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Sclerotherapy Historic Market Review by Type (2015-2020)
4.1.2 Global Sclerotherapy Sales Market Share by Type (2015-2020)
4.1.3 Global Sclerotherapy Revenue Market Share by Type (2015-2020)
4.1.4 Sclerotherapy Price by Type (2015-2020)
4.1 Global Sclerotherapy Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Sclerotherapy Sales Forecast by Type (2021-2026)
4.2.3 Global Sclerotherapy Revenue Forecast by Type (2021-2026)
4.2.4 Sclerotherapy Price Forecast by Type (2021-2026)

5 Global Sclerotherapy Market Size by Application
5.1 Global Sclerotherapy Historic Market Review by Application (2015-2020)
5.1.2 Global Sclerotherapy Sales Market Share by Application (2015-2020)
5.1.3 Global Sclerotherapy Revenue Market Share by Application (2015-2020)
5.1.4 Sclerotherapy Price by Application (2015-2020)
5.2 Global Sclerotherapy Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Sclerotherapy Sales Forecast by Application (2021-2026)
5.2.3 Global Sclerotherapy Revenue Forecast by Application (2021-2026)
5.2.4 Sclerotherapy Price Forecast by Application (2021-2026)

6 North America
6.1 North America Sclerotherapy Breakdown Data by Company
6.2 North America Sclerotherapy Breakdown Data by Type
6.3 North America Sclerotherapy Breakdown Data by Application
6.4 North America Sclerotherapy Breakdown Data by Countries
6.4.1 North America Sclerotherapy Sales by Countries
6.4.2 North America Sclerotherapy Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Sclerotherapy Breakdown Data by Company
7.2 Europe Sclerotherapy Breakdown Data by Type
7.3 Europe Sclerotherapy Breakdown Data by Application
7.4 Europe Sclerotherapy Breakdown Data by Countries
7.4.1 Europe Sclerotherapy Sales by Countries
7.4.2 Europe Sclerotherapy Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Sclerotherapy Breakdown Data by Company
8.2 Asia Pacific Sclerotherapy Breakdown Data by Type
8.3 Asia Pacific Sclerotherapy Breakdown Data by Application
8.4 Asia Pacific Sclerotherapy Breakdown Data by Regions
8.4.1 Asia Pacific Sclerotherapy Sales by Regions
8.4.2 Asia Pacific Sclerotherapy Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Sclerotherapy Breakdown Data by Company
9.2 Latin America Sclerotherapy Breakdown Data by Type
9.3 Latin America Sclerotherapy Breakdown Data by Application
9.4 Latin America Sclerotherapy Breakdown Data by Countries
9.4.1 Latin America Sclerotherapy Sales by Countries
9.4.2 Latin America Sclerotherapy Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sclerotherapy Breakdown Data by Type
10.2 Middle East and Africa Sclerotherapy Breakdown Data by Application
10.3 Middle East and Africa Sclerotherapy Breakdown Data by Countries
10.3.1 Middle East and Africa Sclerotherapy Sales by Countries
10.3.2 Middle East and Africa Sclerotherapy Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 BTG
11.1.1 BTG Corporation Information
11.1.2 BTG Business Overview and Total Revenue (2019 VS 2018)
11.1.3 BTG Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 BTG Sclerotherapy Products and Services
11.1.5 BTG SWOT Analysis
11.1.6 BTG Recent Developments
11.2 Kreussler
11.2.1 Kreussler Corporation Information
11.2.2 Kreussler Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Kreussler Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Kreussler Sclerotherapy Products and Services
11.2.5 Kreussler SWOT Analysis
11.2.6 Kreussler Recent Developments
11.3 LGM Pharma
11.3.1 LGM Pharma Corporation Information
11.3.2 LGM Pharma Business Overview and Total Revenue (2019 VS 2018)
11.3.3 LGM Pharma Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 LGM Pharma Sclerotherapy Products and Services
11.3.5 LGM Pharma SWOT Analysis
11.3.6 LGM Pharma Recent Developments
11.4 Troikaa
11.4.1 Troikaa Corporation Information
11.4.2 Troikaa Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Troikaa Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Troikaa Sclerotherapy Products and Services
11.4.5 Troikaa SWOT Analysis
11.4.6 Troikaa Recent Developments
11.5 Changan Tianyu group
11.5.1 Changan Tianyu group Corporation Information
11.5.2 Changan Tianyu group Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Changan Tianyu group Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Changan Tianyu group Sclerotherapy Products and Services
11.5.5 Changan Tianyu group SWOT Analysis
11.5.6 Changan Tianyu group Recent Developments
11.6 Bioniche Pharma Group Ltd
11.6.1 Bioniche Pharma Group Ltd Corporation Information
11.6.2 Bioniche Pharma Group Ltd Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Bioniche Pharma Group Ltd Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Bioniche Pharma Group Ltd Sclerotherapy Products and Services
11.6.5 Bioniche Pharma Group Ltd SWOT Analysis
11.6.6 Bioniche Pharma Group Ltd Recent Developments
11.7 Omega Pharmaceuticals
11.7.1 Omega Pharmaceuticals Corporation Information
11.7.2 Omega Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Omega Pharmaceuticals Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Omega Pharmaceuticals Sclerotherapy Products and Services
11.7.5 Omega Pharmaceuticals SWOT Analysis
11.7.6 Omega Pharmaceuticals Recent Developments
11.8 Angiodynamics
11.8.1 Angiodynamics Corporation Information
11.8.2 Angiodynamics Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Angiodynamics Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Angiodynamics Sclerotherapy Products and Services
11.8.5 Angiodynamics SWOT Analysis
11.8.6 Angiodynamics Recent Developments
11.9 ENDO-FLEX
11.9.1 ENDO-FLEX Corporation Information
11.9.2 ENDO-FLEX Business Overview and Total Revenue (2019 VS 2018)
11.9.3 ENDO-FLEX Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 ENDO-FLEX Sclerotherapy Products and Services
11.9.5 ENDO-FLEX SWOT Analysis
11.9.6 ENDO-FLEX Recent Developments
11.10 MTW ENDOSKOPIE
11.10.1 MTW ENDOSKOPIE Corporation Information
11.10.2 MTW ENDOSKOPIE Business Overview and Total Revenue (2019 VS 2018)
11.10.3 MTW ENDOSKOPIE Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 MTW ENDOSKOPIE Sclerotherapy Products and Services
11.10.5 MTW ENDOSKOPIE SWOT Analysis
11.10.6 MTW ENDOSKOPIE Recent Developments
11.11 Cook Medical
11.11.1 Cook Medical Corporation Information
11.11.2 Cook Medical Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Cook Medical Sclerotherapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Cook Medical Sclerotherapy Products and Services
11.11.5 Cook Medical SWOT Analysis
11.11.6 Cook Medical Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Sclerotherapy Sales Channels
12.2.2 Sclerotherapy Distributors
12.3 Sclerotherapy Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Sclerotherapy Sales Forecast (2021-2026)
13.1.1 Global Sclerotherapy Sales Forecast by Regions (2021-2026)
13.1.2 Global Sclerotherapy Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Sclerotherapy Sales Forecast (2021-2026)
13.2.2 North America Sclerotherapy Revenue Forecast (2021-2026)
13.2.3 North America Sclerotherapy Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Sclerotherapy Sales Forecast (2021-2026)
13.3.2 Europe Sclerotherapy Revenue Forecast (2021-2026)
13.3.3 Europe Sclerotherapy Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Sclerotherapy Sales Forecast (2021-2026)
13.4.2 Asia Pacific Sclerotherapy Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Sclerotherapy Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Sclerotherapy Sales Forecast (2021-2026)
13.5.2 Latin America Sclerotherapy Revenue Forecast (2021-2026)
13.5.3 Latin America Sclerotherapy Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Sclerotherapy Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Sclerotherapy Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Sclerotherapy Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

BTG、Kreussler、LGM Pharma、Troikaa、Changan Tianyu group、Bioniche Pharma Group Ltd、Omega Pharmaceuticals、Angiodynamics、ENDO-FLEX、MTW ENDOSKOPIE、Cook Medical

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 硬化療法の世界市場2020-2026:洗剤、浸透圧剤、化学刺激剤(Global Sclerotherapy Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。